General form for registration of securities under the Securities Act of 1933

Income Taxes (Tables)

v3.25.2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense (Benefit)

The Company recorded the below income tax expense (benefit) attributable to income from continuing operations for the year ending December 31, 2024 and December 31, 2023 as follows:

 

             
    December 31,  
    2024     2023  
    (In thousands, except percentages)  
Current                
Federal   $ (7 )   $   -  
State     21       -  
Foreign     (34 )     -  
Current, Total     (20 )     -  
Deferred                
Federal     -       -  
State     -       -  
Foreign     -       -  
Deferred, Total     -       -  
Total income tax expense   $ (20 )   $ -  
Schedule of Effective Income Tax Rate Reconciliation

The reconciliation of the provision computed at the federal statutory rate to the Company’s provision (benefit) for income taxes as follows:

 

                             
    December 31,  
    2024     2023  
    (In thousands, except percentages)  
Tax at federal statutory rate   $ (15,432 )     (21.0 )%   $ (28,354 )     (21.0 )%
State, net of federal benefit     12,779       17.4 %     (6,507 )     (4.8 )%
Stock based compensation     3,327       3.8 %     967       0.7 %
Fair value adjustments     (7,593 )     (9.6 )%     (3,555 )     (2.4 )%
Research and development credits           %     (1,121 )     (0.8 )%
Section 382 Limitation     14,583       19.8 %                
Other     (745 )     (1.0 )%     675       0.2 %
Change in valuation allowance     (6,939 )     (9.4 )%     37,895       28.1 %
Total provision for income taxes   $ (20 )     %   $       %
Schedule of Components of Deferred Tax Assets and Liabilities

 

             
    December 31,  
    2024     2023  
    (In thousands)  
Deferred tax assets                
Net operating loss carryforwards   $ 81,649     $ 91,668  
Research and development tax credits     5,086       12,087  
Stock based compensation     5,866       6,162  
Lease liability     2,632       3,098  
Section 174 research and development capitalization     10,691       11,641  
Interest expense     7,157       3,063  
Other timing differences     8,754       1,408  
Total deferred tax assets   $ 121,835     $ 129,127  
Valuation allowance   $ (118,783 )   $ (125,722 )
Net deferred tax assets   $ 3,052     $ 3,405  
                 
Deferred tax liabilities                
Fixed assets and intangibles   $ (299 )   $ (364 )
Right of use assets   $ (2,753 )   $ (3,041 )
Total deferred tax liabilities   $ (3,052 )   $ (3,405 )
Net deferred tax assets   $     $  
Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows:

 

             
    December 31,  
    2024     2023  
    (In thousands)  
Balance at beginning of year   $ 6,060     $ 4,750  
Additions based on tax positions related to the current year     (3,301 )     1,310  
Balance at end of year   $ 2,759     $ 6,060